Stay updated on Selinexor Plus DRd in New Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Selinexor Plus DRd in New Multiple Myeloma Clinical Trial page.

Latest updates to the Selinexor Plus DRd in New Multiple Myeloma Clinical Trial page
- ChecktodayChange DetectedRevision in the study record history updated from v3.6.0 to v3.6.2, indicating a newer version of the page's history entry. This reflects a maintenance/update to the page rather than changes to the underlying study data or content.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedA new version of the study record (v3.6.0) was released, and the recruitment status was updated to 'No longer looking for participants'. The update adds sections for Adverse Events, Outcome Measures (Results), Baseline Characteristics, Participant Flow, and other document sections to reflect the current state of the trial.SummaryDifference2%

- Check22 days agoChange DetectedA new revision entry (v3.5.5) was added to the study record history, and the previous revision (v3.5.4) was removed, updating the version history.SummaryDifference0.1%

- Check36 days agoChange DetectedThe version history now shows a 'Results Submitted' status, replacing the previous 'No Results Posted' label and indicating that study results have been submitted for the record.SummaryDifference0.1%

- Check43 days agoChange DetectedThe page history now shows revision v3.5.4, replacing the previous v3.5.3, representing a new release of the record history section. It updates the versioning information without altering the underlying study data or displayed content.SummaryDifference0.1%

- Check64 days agoChange DetectedThe page footer revision/version updates from “Revision: v3.5.2” to “Revision: v3.5.3.” This indicates an interface/software release without changing the study history content itself.SummaryDifference0.1%

Stay in the know with updates to Selinexor Plus DRd in New Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Selinexor Plus DRd in New Multiple Myeloma Clinical Trial page.